Diabetes and COVID-19: A review
https://doi.org/10.15605/jafes.035.01.06
- Author:
Arjun Baidya
1
;
Santosh Kumar Singh
2
;
Sarita Bajaj
3
;
Abdul Hamid Zargar
4
;
Parminder Singh
5
;
Sambit Das
6
;
Anand Shankar
7
Author Information
1. Department of Endocrinology, Nil Ratan Sircar Medical College, Kolkata, India
2. Endocrinology and Diabetes Clinic, Patna, India
3. Department of Medicine, Motilal Nehru Medical College, Allahabad, India
4. Centre for Diabetes and Endocrine Care, National Highway Gulshan Nagar Srinagar, Jammu and Kashmir, India
5. Department of Endocrinology, Dayanand Medical College and Hospital, Ludhiana, India
6. Apollo Hospital, Bhubaneswar, India
7. Shankar Diabetes Care, Patna, India
- Publication Type:Review
- Keywords:
Corona Virus
- MeSH:
COVID-19;
Diabetes Mellitus
- From:
Journal of the ASEAN Federation of Endocrine Societies
2020;35(1):40-48
- CountryPhilippines
- Language:English
-
Abstract:
Coronavirus Disease 2019 (COVID-19) is an emerging disease and since its first identification in Wuhan, China, in December 2019, there has been a rapid increase in cases and deaths across the world. COVID-19 has been shown to have an immense impact in infected persons with diabetes, worsening their outcome, especially in elderly, smokers, obese, those having CVD, CKD, poor glycemic control and long duration of diabetes. In this review we summarize the current understanding of `the impact of COVID-19 on diabetes and discusses the pathophysiological mechanisms and management of diabetes and its complication in this scenario.
- Full text:805-Article Text-9901-2-10-20200529.pdf
